Sutro Biopharma (STRO) Receivables - Net (2017 - 2026)
Sutro Biopharma (STRO) posted Receivables - Net of $5.8 million for Q2 2026, down 27.5% from $8 million a year earlier.
Analysis
Sutro Biopharma (STRO) Receivables - Net (2017 - 2026) Analysis & Trends
At the end of FY2025, Sutro Biopharma's Receivables - Net came in at $3.98 million, down 53.8% from FY2024.
- Annual Receivables - Net shows a five-year compound annual growth rate of -6.5% (FY2020 to FY2025).
- In prior years, Sutro Biopharma's Receivables - Net was $8.62 million in FY2024 (-76.1%), $36.08 million in FY2023 (+406.6%), $7.12 million in FY2022 (-42.8%) and $12.45 million in FY2021 (+124.0%).
- Quarterly Receivables - Net has run from a low of $3.92 million in Q3 2025 to a high of $97.67 million in Q2 2022 over five years.
- On a year-over-year basis, Receivables - Net increased in 1 of the last seven quarters, with an average decline of 42.9%.
- The strongest year-over-year quarter for Receivables - Net in the past five years was Q2 2022, with growth of 966.3%; the weakest was Q2 2023, with a decline of 89.8%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Sutro Biopharma | 265.72 Mn | -412.78 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.80 Mn |
| Dec 31, 2025 | 3.98 Mn |
| Sep 30, 2025 | 3.92 Mn |
| Jun 30, 2025 | 8.00 Mn |
| Mar 31, 2025 | 13.56 Mn |
| Dec 31, 2024 | 8.62 Mn |
| Sep 30, 2024 | 6.66 Mn |
| Jun 30, 2024 | 6.95 Mn |
| Mar 31, 2024 | 31.30 Mn |
| Dec 31, 2023 | 36.08 Mn |
| Sep 30, 2023 | 16.63 Mn |
| Jun 30, 2023 | 10.00 Mn |
| Mar 31, 2023 | 9.87 Mn |
| Dec 31, 2022 | 7.12 Mn |
| Sep 30, 2022 | 11.24 Mn |
| Jun 30, 2022 | 97.67 Mn |
| Mar 31, 2022 | 11.69 Mn |
| Dec 31, 2021 | 12.45 Mn |
| Sep 30, 2021 | 12.33 Mn |
| Jun 30, 2021 | 9.16 Mn |
API Access
Sutro Biopharma Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=STRO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "STRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=STRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();